Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leigh Ellis

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Medical Oncology (Northwood, London, England)|September 28, 2021
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signalingErika Heninger, David Kosoff, Tamara S Rodems, et al.
Cancer Research Communications|August 8, 2024
MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate CancerBeatriz German, Sarah A Alaiwi, Kun-Lin Ho, et al.
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
Research Square|September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerLeigh Ellis, Beatriz German, Katherine Morel, et al.
Nature Communications|February 4, 2022
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasisYiwu Yan, Bo Zhou, Chen Qian, et al.
Cell Death & Disease|June 2, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancerDanielle Meiwen Fang, Raj K Shrestha, Beatriz German, et al.
Nature Communications|April 23, 2024
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acidsGabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.
Molecular Cancer Research : MCR|May 29, 2020
Targeting RET Kinase in Neuroendocrine Prostate CancerHalena R VanDeusen, Johnny R Ramroop, Katherine L Morel, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|September 28, 2021
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signalingErika Heninger, David Kosoff, Tamara S Rodems, et al.
Cancer Research Communications|August 8, 2024
MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate CancerBeatriz German, Sarah A Alaiwi, Kun-Lin Ho, et al.
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
Research Square|September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerLeigh Ellis, Beatriz German, Katherine Morel, et al.
Nature Communications|February 4, 2022
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasisYiwu Yan, Bo Zhou, Chen Qian, et al.
Cell Death & Disease|June 2, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancerDanielle Meiwen Fang, Raj K Shrestha, Beatriz German, et al.
Nature Communications|April 23, 2024
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acidsGabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.
Molecular Cancer Research : MCR|May 29, 2020
Targeting RET Kinase in Neuroendocrine Prostate CancerHalena R VanDeusen, Johnny R Ramroop, Katherine L Morel, et al.
Pageof 7